| P | Preterm infants </= 37 weeks |
| I | Vasopressin |
| C | Placebo or standard practice |
| O | Efficacy (i.e., is it effective as treatment for hypotension?) and safety (what are the adverse effects?) |
| S | N/A |
| P | Preterm infants </= 37 weeks |
| I | Vasopressin |
| C | Placebo or standard practice |
| O | Efficacy (i.e., is it effective as treatment for hypotension?) and safety (what are the adverse effects?) |
| S | N/A |